File:6-diazo-5-oxo-L-norleucine.png - Wikimedia Commons
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram
6-Diazo-5-oxo-L-norleucine - Wikipedia
FD49029 | 157-03-9 | 6-Diazo-5-oxo-L-norleucine
6-Diazo-5-oxo-L-norleucine - LabNet Biotecnica
6-diazo-5-oxo-L-norleucine | C6H9N3O3 - PubChem
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
6-Diazo-5-oxo-L-nor-Leucine (L-6-Diazo-5-oxonorleucine) | Glutaminases Antagonist | MedChemExpress
6 Diazo 5 Oxonorleucine - an overview | ScienceDirect Topics
6-Diazo-5-oxo-L-norleucine | C6H9N3O3 | ChemSpider
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
The glutamine antagonist 6-diazo-5-oxo-L-norleucine is the most... | Download Scientific Diagram
Chemical reactivity of 6-diazo-5-oxo-l-norleucine (DON) catalyzed by metalloporphyrins (Fe,Ru) - ScienceDirect
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram
6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich
6 Diazo 5 Oxonorleucine - an overview | ScienceDirect Topics
a U251 were treated with l-asparaginase and/or... | Download Scientific Diagram
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
6-Diazo-5-oxo-L-norleucine | ≥99%(HPLC) | Selleck | Glutaminase antagonist
6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich
6-Diazo-5-oxo-L-norleucine for Sale from Quality Suppliers - ECHEMI
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of Medicinal Chemistry
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
